Pharvaris N.V.(PHVS) - 2025 FY - Earnings Call Transcript

Pharvaris (PHVS) FY 2025 Conference February 12, 2025 09:20 AM ET Company Participants Wim Souverijns - CCOPeng Lu - Chief Medical Officer Conference Call Participants Jeff Jones - Managing Director - Senior Analyst Jeff Jones Alright. Good morning, everyone, and welcome back to the Oppenheimer Healthcare Conference. I'm I'm Jeff Jones, one of the biotechnology analysts here on the team, and I'm joined by the team from Farvaris. Farvaris is a late clinical stage company developing, the novel oral bradykinin ...